2 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow Overactive Bladder (OAB): new trials by email Literature Review of Overactive Bladder (OAB) trials Research Report on Overactive Bladder (OAB)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder NT 201 200U and Vibe System, NT 201 300U and Vibe System, Placebo and sham - Overactive Bladder (OAB) | Phase 2 | Recruiting | Vensica Therapeutics Ltd. | 210 | 2026-08-14 | 2026-10-16 |
| Zinc Supplementation With Botulinum Toxin for Overactive Bladder Zinc Citrate Oral Capsule, Placebo - Overactive Bladder (OAB) | Phase 2 | Recruiting | Endeavor Health | 72 | 2026-02-26 | 2026-07-02 |
Urinary Bladder, Overactive (2)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Lower Urinary Tract Symptoms (2) · Male Urogenital Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Urinary Bladder Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Urological Manifestations (2)
incobotulinumtoxinA (1) · salicylhydroxamic acid (1)
Endeavor Health (1) · Vensica Therapeutics Ltd. (1)
United States (2)